SPRY filings
Corporate insider profile
Eric Karas Filing Activity
Latest reported as Chief Commercial Officer of ARS Pharmaceuticals, Inc. (SPRY).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$250,000.00
- Latest transaction
- Jun 12, 2026
Affiliated corporations
Reported company relationships
Transaction history
